https://www.intelliatx.com/crispr-news-item/companies-racing-to-use-crispr-to-fight-disease/ 2017-09-07T11:07:43+00:00 https://www.intelliatx.com/crispr-news-item/a-year-of-brutal-training-for-racing-in-the-andes/ 2017-09-07T11:08:11+00:00 https://www.intelliatx.com/crispr-news-item/biotech-execs-blast-trumps-travel-ban/ 2017-09-07T11:08:34+00:00 https://www.intelliatx.com/crispr-news-item/space-is-at-a-premium-for-cambridge-startup-intellia/ 2017-09-07T11:09:01+00:00 https://www.intelliatx.com/crispr-news-item/listen-gene-editing-might-eradicate-disease-or-be-pandoras-box-in-a-bottle/ 2017-09-11T12:26:49+00:00 https://www.intelliatx.com/crispr-news-item/intellias-ceo-nessan-bermingham-phd-on-bloomberg-radio-with-doni-bloomfield/ 2017-09-11T12:27:35+00:00 https://www.intelliatx.com/crispr-news-item/nessan-bermingham-intellia-ceo-and-president-talks-with-cnbc-about-crispr-technology/ 2017-09-11T12:28:23+00:00 https://www.intelliatx.com/crispr-news-item/the-2016-dr-h-p-heineken-prize-for-biochemistry-and-biophysics-awarded-to-jennifer-doudna/ 2017-09-11T12:29:05+00:00 https://www.intelliatx.com/crispr-news-item/doudna-named-foreign-member-of-uks-royal-society/ 2017-09-11T12:29:36+00:00 https://www.intelliatx.com/crispr-news-item/paul-ehrlich-and-ludwig-darmstaedter-prize-for-j-a-doudna-and-e-charpentier/ 2017-09-11T12:30:19+00:00 https://www.intelliatx.com/crispr-news-item/alpert-prize-recognizes-crispr-pioneers/ 2017-09-11T12:30:54+00:00 https://www.intelliatx.com/crispr-news-item/jennifer-doudna-answers-questions-on-crispr-gene-editings-future/ 2017-09-11T12:31:29+00:00 https://www.intelliatx.com/crispr-news-item/and-sciences-breakthrough-of-the-year-is/ 2017-09-11T12:32:23+00:00 https://www.intelliatx.com/crispr-news-item/intellia-therapeutics-appoints-caroline-dorsa-to-companys-board-of-directors/ 2017-09-11T12:33:02+00:00 https://www.intelliatx.com/crispr-news-item/on-human-gene-editing-international-summit-statement/ 2017-09-11T12:33:34+00:00 https://www.intelliatx.com/crispr-news-item/the-crispr-quandary/ 2017-09-11T12:34:06+00:00 https://www.intelliatx.com/crispr-news-item/intellia-raises-70-million-for-gene-editing-treatments/ 2017-09-11T12:35:47+00:00 https://www.intelliatx.com/crispr-news-item/the-age-of-the-red-pen/ 2017-09-11T12:37:44+00:00 https://www.intelliatx.com/crispr-news-item/the-researchers-behind-the-biggest-biotech-discovery-of-the-century-found-it-by-accident/ 2017-09-11T12:38:16+00:00 https://www.intelliatx.com/crispr-news-item/editing-the-software-of-life-for-fame-and-fortune/ 2017-09-11T12:39:00+00:00 https://www.intelliatx.com/crispr-news-item/europa-genes-and-wheels-full-episode-268/ 2017-09-11T12:39:43+00:00 https://www.intelliatx.com/crispr-news-item/emmanuelle-charpentier-jennifer-doudna/ 2017-09-11T12:40:49+00:00 https://www.intelliatx.com/crispr-news-item/who-owns-crispr/ 2017-09-11T12:41:23+00:00 https://www.intelliatx.com/crispr-news-item/mini-enzyme-moves-gene-editing-closer-to-the-clinic/ 2017-09-11T12:42:33+00:00 https://www.intelliatx.com/crispr-news-item/scientists-seek-ban-on-method-of-editing-the-human-genome/ 2017-09-11T12:43:51+00:00 https://www.intelliatx.com/crispr-news-item/nature-biotech-honors-some-of-2014s-best-academic-startups/ 2017-09-11T12:44:19+00:00 https://www.intelliatx.com/crispr-news-item/cart-crispr-1st-of-its-kind-biotech-deal-from-novartis-intellia/ 2017-09-11T12:44:50+00:00 https://www.intelliatx.com/crispr-news-item/novartis-joins-atlas-in-launching-a-crispr-cas-biotech-with-a-15m-bankroll/ 2017-09-11T13:07:29+00:00 https://www.intelliatx.com/crispr-news-item/intellia-closes-on-70-million-series-b-round-plans-to-hire-20/ 2017-09-11T13:46:45+00:00 https://www.intelliatx.com/crispr-news-item/xconomy-crispr-cash-intellia-the-latest-gene-editing-firm-to-nab-big/ 2017-09-11T13:47:23+00:00